DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations

Kidney International

Volumn 53, Issue 5, 1998, Pages 1172-1181

  Wilmer, William A ^a   Cosio, Fernando G ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Binding of AP 1; Diabetes progression; Extracellular matrix; Gene regulation; Phosphoproteins; Protein kinase C; Transforming growth factor

Indexed keywords

GLUCOSE; SCLEROPROTEIN; SYNAPSIN I;

ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESANGIUM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN MODIFICATION;

EID: 0031847608     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00888.x     Document Type: Article

References (74)

1. MAUER SM, STEFFES MW, ELLIS EN, SUTHERLAND DER, BROWN DM, GOETZ FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
2. STEFFES MW, OSTERBY R, CHAVERS B, MAUER SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. (review) Diabetes 38:1077-1081, 1989
3. FIORETTO P, STEFFES MW, SUTHERLAND DER, MAUER M: Sequential renal biopsies in insulin-dependent diabetic patients: Structural factors associated with clinical progression. Kidney Int 48:1929-1935, 1995
4. STEFFES MW, BILOUS RW, SUTHERLAND DE, MAUER SM: Cell and matrix components of the glomerular mesangium in type 1 diabetes. Diabetes 41:679-684, 1992
5. AYO SH, RADNIK RA, GLASS WF III, GARONI JA, RAMPI ER, APPLING DR, KREISBERG JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260(Pt 2):F185-F191, 1991
6. FUMO P, KUNCIO GS, ZIYADEH FN: PKC and high glucose stimulate collagen alpha 1 (IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267(Pt 2):F632-F638, 1994
7. KREISBERG JI, KREISBERG SH: High glucose activates protein kinase C and stimulates fibronectin gene expression by enhancing a c-AMP response element. kidney Int 48(Suppl 51):S3-S11, 1995
8. HARRIS RD, STEFFES MW, BILOUS RW, SUTHERLAND DE, MAUER SM: Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40:107-114, 1991
9. MCLENNAN SV, FISHER EJ, YUE DK, TURTLE JR: High glucose concentration causes a decrease in mesangium degradation, a factor in the pathogenesis of diabetic nephropathy. Diabetes 43:1041-1045, 1994
10. ZIYADEH FN: Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease (review). Miner Electrolyte Metab 21:292-302, 1995
11. DAVIES M, MARTIN J, THOMAS GJ, LOVETT DH: Proteinases and glomerular matrix turnover. (review) Kidney Int 41:671-678, 1992
12. NAHMAN NS, LEONHART KL, COSIO FG, HEBERT CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 41:396-402, 1992
13. PUGLIESE G, PRICCI F, PUGLIESE F, MENE P, LENTI L, ANDREANI D, GALLI G, CASINI A, BIANCHI S, ROTELLA CM, DIMARIO U: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490, 1996
14. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
15. SHANKLAND SJ, SCHOLEY JW, LY H, THAI K: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
16. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
17. HAI T, CURRAN T: Cross-family dimerization of transcription factors fos/jun and atf/creb alters dna binding specificity. Proc Natl Acad Sci USA 88:3720-3724, 1991
18. BOYLE WJ, SMEAL T, DEFIZE LH, ANGEL P, WOODGETT JR, KARIN M, HUNTER T: Activation of protein kinase C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell 64:573-584, 1991
19. WHITMARSH AJ, DAVIS RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607, 1996
20. KARIN M: The regulation of AP-1 activity by mitogen-activated protein kinases. (review) Philosophical Trans Royul Soc Lond (Series B: Biol Sci) 351:127-134, 1996
21. KREISBERG JI, RADNIK RA, AYO SH, GARONI J, SAIKUMAR P: High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int 46:105-112, 1994
22. COSIO FG, WILMER WA: Effects of high glucose concentration on c-fos: Role of protein kinase C. Kidney Int 48(Suppl 51):S12-S17, 1995
23. ANGEL P, HATTORI K, SMEAL T, KARIN M: The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885, 1988
24. HATTORI K, ANGEL P, LE BEAU MM, KARIN M: Structure and chromosomal localization of the functional intronless human jun protooncogene. Proc Natl Acad Sci USA 85:9148-9152, 1988
25. KERPPOLA TK, CURRAN T: Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: Implications for transcription factor cooperativity. Cell 66:317-326, 1991
26. ABATE C, LUK D, CURRAN T: Transcriptional regulation by Fos and Jun in vitro: Interaction among multiple activator and regulatory domains. Molec Cell Biol 11:3624-3632, 1991
27. ANGEL P, KARIN M: The role of Jun, Fos and the AP-Icomplex in cell-proliferation and transformation. (review) Biochim Biophys Acta 1072:129-157, 1991
28. HUNTER T, KARIN M: The regulation of transcription by phosphorylation. (review) Cell 70:375-387, 1992
29. MINDEN A, LIN A, SMEAL T, DÉRIJARD B, COBB M, DAVIS R, KARIN M: c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 14:6683-6688, 1994
30. KYRIAKIS JM, BANERJEE P, NIKOLAKAKI E, DAI T, RUBIE EA, AHMAD MF, AVRUCH J, WOODGETT JR: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160, 1994
31. WOODGETT JR, AVRUCH J, KYRIAKIS JM: Regulation of nuclear transcription factors by stress signals. Clin Exp Pharmacol Physiol 22:281-283, 1995
32. DIGNAM JD, LEBOVITZ RM, ROEDER RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489, 1983
33. OSBORN L, KUNKEL S, NABEL, GJ: Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 86:2336-2340, 1989
34. BRUNS RF, MILLER FD. MERRIMAN RL, HOWBERT JJ, HEATH WF, KOBAYASHI E, TAKAHASHI I, TAMAOKI T, NAKANO H: Inhibition of protein kinase C by calphostin C is light- dependent. Biochem Biophys Res Commun 176:288-293, 1991
35. WILMER WA, TAN LC, DICKERSON JA, DANNE M, ROVIN BH: Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells: Role of oxidation. J Biol Chem 272:10877-10881, 1997
36. 3d. RIGGS A, SUZUKI H, BOURGEOIS S: Lae repressor-operator interactions. I. Equilibrium studies. J Molec Biol 48:67-83, 1970
37. SIMONSON MS: Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Physiol 26(Pt 2):F805-F815, 1994
38. CANO E, HAZZALIN CA, KARDALINOU E, BUCKLE RS, MAHADEVAN LC: Neither ERK nor JNK/SAPK MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation or c-fos and c-jun induction. J Cell Sci 108:3599-3609, 1995
39. CHIU R, BOYLE WJ, MEEK J, SMEAI T, HUNTER T, KARIN M: The c-fos protein interacts with e-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541-552, 1988
40. WAKISAKA M, SPIRO MJ, SPIRO RG: Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. Diabetes 43:95-103, 1994
41. SMITH SE, BOHMANN D: Functional dissection of AP-1 transcription factors using the GAL4 adaptor assay. Cell Growth Differ 3:523-529, 1992
42. LIN A, SMEAL T, BINETRUY B, DENG T, CHAMBARD JC, KARIN M: Control of AP-1 activity by signal transduction cascades. (review) Advances in Second Messenger & Phosphoprotein Research 28:255-260, 1993
43. DENG T, KARIN M: Jun B differs from c-Jun in its DNA-binding and dimerization domains, and represses e-jun by formation of inactive heterodimers. Genes Develop 7:479-490, 1993
44. CHIU R, ANGEL P, KARIN M: Jun-B differs in its biological properties from, and is a negative regulator of, c-jun. Cell 59:979-986, 1989
45. WOODGETT JR, PULVERER BJ, NIKOLAKAKI E, PLYTE S, HUGHES K, FRANKLIN CC, KRAFT AS: Regulation of Jun/AP-1 oncoproteins by protein phosphorylation. (review) Advances in Second Messenger & Phosphoprotein Research 28:261-269, 1993
46. KOUZARIDES T, ZIFF E: The role of the leucine zipper in the Fos-Jun interaction. Nature 336:646-651, 1988
47. ALLEGRETTO EA, SMEAL T, ANGEL P, SPIEGELMAN BM, KARIN M: DNA-binding activity of Jun is increased through its interaction with Fos. J Cell Biochem 42:193-206, 1990
48. SMEAL T, ANGEL P, MEEK J, KARIN M: Different requirements for formation of Jun:Jun and Jun:Fos complexes. Genes Develop 3:2091-2100, 1989
49. AUWERX J, SASSONE-CORSI P: AP-1 (Fos-Jun) regulation by IP-1: Effect of signal transduction pathways and cell growth. Oncogene 7:2271-2280, 1992
50. ABATE C, BAKER SJ, LEES-MILLER SP, ANDERSON CW, MARSHAK DR, CURRAN T: Dimerization and DNA binding alter phosphorylation of Fos and Jun. Proc Natl Acad Sci USA 90:6766-6770, 1993
51. NIKOLAKAKI E, COFFER PJ, HEMELSOET R, WOODGETT JR, DEFIZE LH: Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 8:833-840, 1993
52. LIN A, FROST J, DENG T, SMEAL T, AL-ALAWI N, KIKKAWA U, HUNTER T, BRENNER D, KARIN M: Casein kinase II is a negative regulator of c-jun DNA binding and AP-1 activity. Cell 70:777-789, 1992
53. GOODE N, HUGHES K, WOODGETT JR, PARKER PJ: Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 67:16878-16882, 1992
54. KARINCH AM, KIMBALL SR, VARY TC, JEFFERSON LS: Regulation of eukaryotic initiation factor-2b activity in muscle of diabetic rats. Am J Physiol 264(Pt 1):E101-E108, 1993
55. RAUSCHER FJ III, COHEN DR, CURRAN T, BOS TJ, VOGT PK, BOHMANN D, TJIAN R, FRANZA BR JR: Fos-associated protein p39 is the product of the jun proto-oncogene. Science 240:1010-1016, 1988
56. WILLIAMS B, SCHRIER RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-1472, 1992
57. XIA P, INOGUCHI T, KERN TS, ENGERMAN RL, OATES PJ, KING GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
58. HANEDA M, ARAKI S, TOGAWA M, SUGIMOTO T, ISONO M, KIKKAWA R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
59. SIMONSON MS, WANG Y, JONES JM, DUNN MJ: Protein kinase C regulates activation of mitogen-activated protein kinase and induction of proto-oncogene c-fos by endothelin-1. J Cardiovasc Pharmacol 20(Suppl 12):S29-S32, 1992
60. WHITMARSH AJ, SHORE P, SHARROCKS AD, DAVIS RJ: Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407, 1995
61. TANIGUCHI N, KANETO H, ASAHI R, TAKAHASHI M, CHE WY, HIGASHIYAMA S, FUJII J, SUZUKI K, KAYANOKI Y: Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes 45:S81-S83, 1996
62. KASHIWAGI A, ASAHINA T, NISHIO Y, IKEBUCHI M, TANAKA Y, KIKKAWA R, SHIGETA Y: Glycation, oxidative stress, and scavenger activity glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 45:S84-S86, 1996
63. KIM SJ, ANGEL P, LAFYATIS R, HATTORI K, KIM KY, SPORN MB, KARIN M, ROBERTS AB: Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Molec Cell Biol 10:1492-1497, 1990
64. BASCOM CC, WOLFSHOHL JR, COFFEY RJ JR, MADISEN L, WEBB NR, PURICHO AR, DERYNCK R, MOSES HL: Complex regulation of transforming growth factor β 1, β 2 and β 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β 1 and β 2. Mol Cell Biol 9:5508-5515, 1995
65. WOLF G, SHARMA K, CHEN Y, ERICKSEN M, ZIYADEH FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42:647-656, 1992
66. SHARMA K, ZIYADEH FN: Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and nod mouse. Am J Physiol 267(Pt 2):F1094-F10100, 1994
67. YING Z, REISMAN D, BUGGY J: AP-1 DNA binding activity induced by hyperosmolality in the rat hypothalamic supraoptic and paraventricular nuclei. Mol Brain Res 39:109-116, 1996
68. Xu Q, LIU Y. GOROSPE M, UDELSMAN R, HOLBROOK NJ: Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 97:508-514, 1996
69. ASIEDU C, SCOTTO L, ASSOIAN R, EHRLICH M: Binding of AP-1/ CREB and of MDBP to continguous sites downstream of the human TGF-betal gene. Biochim Biophys Acta 1219:55-63, 1994
70. GUPTA S, BARRETT T, WHITMARSII AJ, CAVANAGH J, SLUSS HK, DÉRIJARD B, DAVIS RJ: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15:2760-2770, 1996
71. AKAI Y, HOMMA T, BURNS KD, YASUDA T, BADR KF, HARRIS RC: Mechanical stretch/relaxation of cultured rat mesangial cells induces protooncogenes and cyclooxygenase. Am J Physiol 267(Pt 1):C482-C490, 1994
72. 2-terminal kinases. J Biol Chem 271:15703-15707, 1996
73. SCHONTHAL A, BUSCHER M, ANGEL P, RAHMSDORF HJ, PONTA H, HATTORI K, CHIU R, KARIN M, HERRLICH P: The Fos and Jun/AP-1 proteins are involved in the downregulation of fos transcription. Oncogene 4:629-636, 1989
74. GAUTHIER-ROUVIERE C, BASSET M, LAMB NJ, FERNANDEZ A: Role of Fos-AP-1 binding sequence (fap) in the induction of c-fos expression by purified C-kinase and in c-fos down-regulation following serum induction. Oncogene 7:363-369, 1992